Literature DB >> 27928589

Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia.

Hong Wang1,2, Mingqiang Hua1, Shukang Wang3, Jie Yu1, Chen Chen1, Xueyun Zhao1, Chen Zhang1, Chaoqin Zhong1, Ruiqing Wang1, Na He1, Ming Hou1, Daoxin Ma4.   

Abstract

BACKGROUND: Though the pathogenesis of AML is still unknown, accumulating evidence revealed that immune response plays a vital part in it. NLRP3 inflammasome as a component of immune system has been found related to several cancers. The single nucleotide polymorphisms (SNPs) of NLRP3 inflammasome genes may be related to pathogenesis and prognosis of AML. METHODS AND
RESULTS: We determined polymorphisms of NLRP3 (rs35829419), CARD8 (rs2043211), IL-1β (rs16944), IL-18 (rs1946518) and NF-κB -94 ins/del ATTG in de novo AML patients to find out whether they play roles in the susceptibility and severity of AML. In our study, 383 AML cases and 300 randomly selected healthy individuals were examined for the polymorphisms and expression of NLRP3 genes. IL-1β (rs16944) polymorphism in different risk AML subgroups was found statistically different, with more GA genotype in favorable-risk cytogenetics group. We also demonstrated that the bone marrow blasts of patients carrying IL-18 (rs1946518) GG or GT genotype were higher than patients of TT genotype. IL-18 plasma level of patients with IL-18 (rs1946518) GT or TT genotype was higher than GG genotype. Moreover, the GT genotype of IL-18 (rs1946518) led to statistically poorer AML-specific survival.
CONCLUSION: IL-1β (rs16944) and IL-18 (rs1946518) may be served as potential predictors for AML.

Entities:  

Keywords:  Acute myeloid leukemia; Inflammasome, NLRP3; Polymorphism; Susceptibility

Mesh:

Substances:

Year:  2016        PMID: 27928589     DOI: 10.1007/s00011-016-1012-4

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  37 in total

Review 1.  Cytokine gene polymorphism in human disease: on-line databases.

Authors:  J Bidwell; L Keen; G Gallagher; R Kimberly; T Huizinga; M F McDermott; J Oksenberg; J McNicholl; F Pociot; C Hardt; S D'Alfonso
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

Review 2.  Intracellular NOD-like receptors in host defense and disease.

Authors:  Thirumala-Devi Kanneganti; Mohamed Lamkanfi; Gabriel Núñez
Journal:  Immunity       Date:  2007-10       Impact factor: 31.745

3.  Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.

Authors:  Yuki Kagoya; Akihide Yoshimi; Keisuke Kataoka; Masahiro Nakagawa; Keiki Kumano; Shunya Arai; Hiroshi Kobayashi; Taku Saito; Yoichiro Iwakura; Mineo Kurokawa
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

4.  Expression of interleukin-1beta in human breast carcinoma.

Authors:  L Jin; R Q Yuan; A Fuchs; Y Yao; A Joseph; R Schwall; S J Schnitt; A Guida; H M Hastings; J Andres; G Turkel; P J Polverini; I D Goldberg; E M Rosen
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

5.  Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells.

Authors:  M L Guzman; S J Neering; D Upchurch; B Grimes; D S Howard; D A Rizzieri; S M Luger; C T Jordan
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

6.  Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival.

Authors:  M G Alexandrakis; F H Passam; K Sfiridaki; J Moschandrea; C Pappa; D Liapi; E Petreli; P Roussou; D S Kyriakou
Journal:  Leuk Res       Date:  2004-03       Impact factor: 3.156

7.  Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population.

Authors:  T Takada; E Suzuki; K Morohashi; F Gejyo
Journal:  Tissue Antigens       Date:  2002-07

Review 8.  IL-1, IL-18, and IL-33 families of cytokines.

Authors:  William P Arend; Gaby Palmer; Cem Gabay
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

9.  [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer].

Authors:  Tao Qi; Qian Wang; Lei Zheng; Hong-ling Yang; Jie Bao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2008-05

Review 10.  Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target.

Authors:  Jianbiao Zhou; Ying Qing Ching; Wee-Joo Chng
Journal:  Oncotarget       Date:  2015-03-20
View more
  16 in total

1.  Association of IL-1β, IL-1Ra and FABP1 gene polymorphisms with the metabolic features of polycystic ovary syndrome.

Authors:  Nadia Rashid; Aruna Nigam; Pikee Saxena; S K Jain; Saima Wajid
Journal:  Inflamm Res       Date:  2017-04-12       Impact factor: 4.575

2.  Immunorelated gene polymorphisms associated with acute myeloid leukemia.

Authors:  Q Liu; M Hua; S Yan; C Zhang; R Wang; X Yang; F Han; M Hou; D Ma
Journal:  Clin Exp Immunol       Date:  2020-06-02       Impact factor: 4.330

Review 3.  NF-κB: A Double-Edged Sword Controlling Inflammation.

Authors:  Danhui Liu; Zhenyu Zhong; Michael Karin
Journal:  Biomedicines       Date:  2022-05-27

Review 4.  The inflammasomes: crosstalk between innate immunity and hematology.

Authors:  Valéria de Freitas Dutra; Vinicius Nunes Cordeiro Leal; Alessandra Pontillo
Journal:  Inflamm Res       Date:  2022-10-20       Impact factor: 6.986

5.  PI3K Is a Linker Between L-selectin and PSGL-1 Signaling to IL-18 Transcriptional Activation at the Promoter Level.

Authors:  Jixian Luo
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

6.  Polymorphism in lncRNA AC008392.1 and its interaction with smoking on the risk of lung cancer in a Chinese population.

Authors:  Xiaoting Lv; Zhigang Cui; Hang Li; Juan Li; Zitai Yang; Yanhong Bi; Min Gao; Baosen Zhou; Zhihua Yin
Journal:  Cancer Manag Res       Date:  2018-05-30       Impact factor: 3.989

Review 7.  NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword.

Authors:  Shaima'a Hamarsheh; Robert Zeiser
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

Review 8.  Role of the NLRP3 inflammasome in cancer.

Authors:  Maryam Moossavi; Negin Parsamanesh; Afsane Bahrami; Stephen L Atkin; Amirhossein Sahebkar
Journal:  Mol Cancer       Date:  2018-11-17       Impact factor: 27.401

Review 9.  The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer.

Authors:  Man Wang; Shuai Jiang; Yinfeng Zhang; Peifeng Li; Kun Wang
Journal:  Cancers (Basel)       Date:  2019-09-05       Impact factor: 6.639

10.  NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway.

Authors:  Chaoqin Zhong; Ruiqing Wang; Mingqiang Hua; Chen Zhang; Fengjiao Han; Miao Xu; Xinyu Yang; Guosheng Li; Xiang Hu; Tao Sun; Chunyan Ji; Daoxin Ma
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.